Brave New World Dept.

Why Are People Injecting Themselves with Peptides?

为什么人们开始注射肽类物质?
Health and wellness influencers are hawking unapproved treatments on the gray market. The future of the F.D.A.—and the health of consumers—is at stake.
健康与养生网红正在灰色市场上兜售未经批准的疗法。美国食品药品监督管理局的未来——以及消费者的健康——正岌岌可危。
Peptide chain of bubbles highlighting different parts of the human figure.
Illustration by Sophi Miyoko Gullbrants

About a decade ago, a group of competitive CrossFitters in Charleston, South Carolina, went looking for ways to improve their athletic performance without taking steroids. At the time, members of the fitness community were starting to inject themselves with peptides—short chains of amino acids, sometimes called microproteins, that often act as signalling molecules in the body. Certain peptides were said to enhance strength, energy, endurance, and recovery. They hadn’t been officially approved for use as drugs, however, and many had never been studied in humans. Some of the CrossFitters were patients of a local doctor named Craig Koniver, who had trained in family medicine but went on to offer Botox treatments and skin fillers, as well as I.V. drips that were supposed to slow aging. “People are really enjoying the benefits,” the CrossFitters told Koniver, of peptides. Would he help the group figure out which to inject, in what doses, and how often?

大约十年前,南卡罗来纳州查尔斯顿市的一群竞技性综合健身爱好者开始寻找不用类固醇就能提升运动表现的方法。当时,健身圈已有人开始注射肽类——即短链氨基酸(有时被称为微蛋白),这类物质在体内常充当信号分子。据说某些肽能增强力量、精力、耐力和恢复能力。然而,这些物质尚未被正式批准作为药物使用,其中许多甚至从未在人体上进行过研究。这群健身者中有些人是当地医生克雷格·科尼弗的患者。科尼弗接受过家庭医学培训,后来转而提供肉毒杆菌注射、皮肤填充剂以及号称能延缓衰老的静脉点滴疗法。“人们确实感受到了肽的好处,”健身者们这样告诉科尼弗。他们希望这位医生能帮忙确定该注射哪种肽、使用多大剂量以及注射频率。

Koniver began ordering peptides from compounding pharmacies, which produce custom medications. He tinkered with various doses, often extrapolating from animal studies, and tried some on himself. He gained a reputation for peptide wizardry. “My name got passed around,” he told me. Rick Rubin, the music producer, introduced Koniver to the neuroscientist and podcaster Andrew Huberman, who invited him onto his hugely popular show in 2024. (“You’re going to get blitzed,” Koniver remembers Huberman saying.) On the podcast, Koniver said that “almost everyone I could think of” can benefit from peptides, and he highlighted an “awesome, supersafe” example called BPC-157. In the month that followed, eight hundred new patients requested appointments. He now sees a total of about a thousand; six thousand more are on a wait list. A membership to his practice can cost fifteen thousand dollars a year, suggesting a revenue in the tens of millions. “I could charge more,” Koniver said. “But I want to sleep well at night.”

科尼弗开始从复合药房订购肽类药物,这些药房专门配制定制药物。他尝试了各种剂量,常常借鉴动物研究的数据,甚至在自己身上试验。他因此赢得了“肽类魔法师”的名声。“我的名字就这样传开了,”他告诉我。音乐制作人里克·鲁宾将科尼弗介绍给了神经科学家兼播客主安德鲁·休伯曼,后者在2024年邀请他登上了自己极受欢迎的节目。(“你会被问个不停的,”科尼弗记得休伯曼这样说过。)在播客中,科尼弗声称“我能想到的几乎所有人”都能从肽类药物中获益,并重点介绍了一种“超棒、超级安全”的肽类物质BPC-157。节目播出后的一个月里,有八百名新患者预约就诊。他现在总共接诊约一千名患者;另有六千人在等候名单上。加入他的医疗会员计划年费可达一万五千美元,这意味着数千万美元的收入。“我可以收更高,”科尼弗说,“但我想每晚睡得安稳。”

In February, I flew to Charleston and met with Koniver in a modern red brick building that houses his clinic. He and his wife, Keli, have a sort of his-and-hers practice: she co-founded a wellness spa next door. Koniver greeted me in his waiting room, which featured a soft-rock soundtrack and brochures for serums and stem cells. His bald head, goatee, and glasses made him look like a friendlier version of Walter White, from “Breaking Bad.”

二月,我飞往查尔斯顿,在一栋现代红砖建筑里见到了科尼弗(Koniver),他的诊所就设在此处。他和妻子凯莉(Keli)的诊所堪称“夫妻档”:凯莉在隔壁与人合伙经营着一家健康水疗中心。科尼弗在候诊室迎接我,室内播放着轻摇滚音乐,陈列着各种精华液和干细胞宣传册。他光头、山羊胡、戴眼镜的模样,活像《绝命毒师》里那位沃尔特·怀特——只是看起来更友善些。

“Peptides are usually the opening question we get,” Koniver told me, in his office. He described many of his clients as “the well who want to be super well”—celebrities, politicians, models. “We don’t take insurance, obviously.” I spotted a Raiders helmet signed by Howie Long, a defensive end turned Fox Sports analyst, on a bookshelf. On a computer, Koniver showed me an electronic ordering system that looked much like the one I use to treat hospitalized patients. But his system, unlike mine, allows him to request unapproved peptides in bespoke combinations, or “stacks.”

“肽类通常是客户问的第一个问题,”科尼弗在他的办公室里告诉我。他形容他的许多客户是“健康但想变得更健康的人”——名人、政客、模特。“我们当然不接受保险。”我在书架上发现了一个由前防守端锋、现福克斯体育评论员豪伊·朗签名的突袭者队头盔。在电脑上,科尼弗向我展示了一个电子订购系统,看起来很像我在医院治疗病人时使用的系统。但与我的系统不同,他的系统允许他定制未经批准的肽类组合,或称“肽类套餐”。

Next, Koniver led me to the clinic’s I.V.-infusion room, where he offered me a poke bowl for lunch. Concoctions were scrawled on a dry-erase board like specials in a diner; one was described as “Dr. Koniver’s blend” of vitamins, minerals, and amino acids. He asked me if I’d like a complimentary drip of methylene blue, a chemical dye that is increasingly marketed for improving longevity and memory. I knew it as a last-resort blood-pressure drug that, at high doses, constricts blood vessels so much that it can cause gangrene. I accepted the poke but declined the drip.

接着,科尼弗带我来到诊所的静脉输液室,并请我吃了份波奇碗当午餐。白板上潦草地写着各种配方,像小餐馆的特色菜菜单;其中一款被描述为“科尼弗医生特调”的维生素、矿物质和氨基酸混合剂。他问我是否想免费体验亚甲蓝输液——这种化学染料正被越来越多地宣传为能延年益寿、增强记忆。我知道它本是种最后手段的降压药,高剂量使用时会使血管剧烈收缩,甚至可能导致坏疽。我接受了波奇碗,但婉拒了输液。

After lunch, a new patient, a handsome middle-aged man I’ll call Toby, eased into a recliner topped with a fluffy pillow. A nurse inserted an I.V. into one arm; Koniver shook his other hand, saying, “Welcome aboard!” Toby and his family had recently been in a car accident, but he’d lost trust in most doctors, he said, after they became “obsessed” with viruses and vaccinations during the pandemic. He was glad that Robert F. Kennedy, Jr., the Secretary of Health and Human Services, was getting the country “on the right track.”

午餐后,一位新患者——我且称他为托比(Toby)——缓缓坐进铺着蓬松靠枕的躺椅。这位相貌英俊的中年男子伸出左臂让护士插入静脉输液管,科尼弗则握住他的右手说道:“欢迎登船!”托比说,不久前他和家人遭遇了车祸,但疫情期间医生们对病毒和疫苗的“痴迷”让他对多数医生产生了不信任。他很欣慰看到卫生与公众服务部部长小罗伯特·F·肯尼迪正带领国家“重回正轨”。

“I’m not a big vaccine guy,” Koniver replied. “A lot of them don’t have the data.”

“我可不是什么疫苗拥护者,”科尼弗(Koniver)答道。“很多疫苗都缺乏可靠数据。”

Toby wasn’t here for a peptide injection, but Koniver advised him to try one on a future visit. “I’ve seen tremendous results,” he said. He also said that one of his I.V. drips, which includes methylene blue, makes his patients “feel like they’ve been plugged into an electrical socket.”

托比这次来不是为了注射肽类,但科尼弗建议他下次可以试试。“我见过惊人的效果,”他说。他还提到,他有一种含亚甲蓝的静脉滴注剂,能让患者“感觉像插上了电源插座”。

“Love that!” Toby responded.

“太棒了!”托比回应道。

I was puzzled, perhaps naïvely, that little-studied peptide shots had earned Koniver’s trust, while meticulously studied COVID-19 vaccinations had not. “Anecdotal data means a lot to me,” he said. “Two days after a vaccine, someone has a stroke. Two days later, they’re dead. . . . You see enough of that, it makes an impression.”

我有些困惑,或许是天真的困惑:那些研究甚少的肽类注射剂赢得了科尼弗的信任,而经过严谨研究的新冠疫苗却没有。“个案数据对我很重要,”他说,“有人接种疫苗两天后中风了。再过两天,人就没了……见得多了,自然会留下印象。”

In recent years, federal efforts to control peptides have placed Koniver at odds with public-health agencies. In 2023, during Biden’s Presidency, the Food and Drug Administration placed nineteen peptides, including BPC-157, on a “do not compound” list, citing “potential significant safety risks” that included immune reactions, pancreatitis, and accelerated growth of cancerous cells. In response, Koniver began offering a peptide that differed by a single amino acid. “So far, we’re getting very similar results,” he told me.

近年来,联邦政府管控多肽类物质的举措让科尼弗与公共卫生机构产生了分歧。2023年拜登执政期间,美国食品药品监督管理局以“潜在重大安全风险”为由,将包括BPC-157在内的19种多肽列入“禁止复配”清单,指出其可能引发免疫反应、胰腺炎并加速癌细胞生长。作为回应,科尼弗开始提供一种仅相差一个氨基酸的多肽替代品。“截至目前,我们观察到的效果非常接近。”他告诉我。

In 2024, Koniver was sanctioned by South Carolina public-health officials who found, among other things, that he’d failed to maintain his registration with the Drug Enforcement Administration while prescribing controlled substances, and that he’d neglected to check patient vital signs before administering ketamine. Koniver attributed these lapses to charting issues and said that no patients were harmed. “There was never a clinical complaint,” he added. He paid a ten-thousand-dollar fine and agreed not to administer ketamine or testosterone for a year. The state of New York, where he was also allowed to practice, ordered him to surrender his medical license there.

2024年,科尼弗(Koniver)遭到南卡罗来纳州公共卫生部门的处罚。调查发现,他在开具管制药物处方时未能保持美国缉毒局的注册资格,且在注射氯胺酮前未检查患者生命体征。科尼弗将这些疏失归因于病历记录问题,并强调没有患者因此受到伤害。“从未出现过临床投诉,”他补充道。他支付了一万美元罚款,并同意一年内不实施氯胺酮或睾酮治疗。他同时获准执业的纽约州则要求他上交当地的行医执照。

As far as peptides go, Koniver seemed to support America’s public-health agencies coming under new management. “Some of my patients are very high up in the government,” he said. “They’re extremely concerned about what the F.D.A. is doing to peptides.” In the era of Make America Healthy Again, the popularity of peptides has risen. Many compounding pharmacies are experiencing soaring demand; the Times reported that U.S. imports of gray-market peptides and hormones from China roughly doubled last year. The podcaster Joe Rogan has credited BPC-157 with healing a case of elbow tendonitis in two weeks. Beauty influencers who want deeper tans and enhanced libidos are taking Melanotan II, also known as the “Barbie peptide.” Even New York magazine recently published a freelance writer’s account of self-injecting peptides, titled “Life on Peptides Feels Amazing,” which failed to cite any peer-reviewed research or academic scientists. In February, R.F.K., Jr., said, on Rogan’s podcast, that he had taken peptides himself and that, under his leadership, the F.D.A. would stop restricting many of them. Kennedy, who has railed against the agency’s “aggressive suppression” of unproven treatments, has vowed to “end the war.”

就肽类药物而言,科尼弗似乎支持美国公共卫生机构进行管理层更迭。“我的病人中有不少政府高层人士,”他说,“他们非常担心食品药品监督管理局对肽类药物的管控方式。”在“让美国再次健康”的时代浪潮中,肽类药物的热度持续攀升。多家复方药房的需求量激增;《纽约时报》报道称,去年美国从中国进口的灰色市场肽类与激素类药物数量几乎翻倍。播客主持人乔·罗根曾宣称BPC-157肽让他的肘部肌腱炎在两周内痊愈。追求古铜肤色与提升性欲的美妆博主们正在使用被称为“芭比肽”的 Melanotan II。就连《纽约》杂志最近也刊登了自由撰稿人自行注射肽类药物的亲历报道,标题为《肽类生活令人沉醉》,全文却未引用任何同行评审研究或学术科学家的观点。今年二月,小罗伯特·F·肯尼迪在罗根的播客节目中坦言自己曾服用肽类药物,并承诺若当选将领导食品药品监督管理局解除对多数肽类药物的限制。这位长期抨击该机构“对未经证实疗法进行激进打压”的总统候选人,已立誓要“终结这场战争”。

The human body produces thousands of peptides. Many are portions of proteins which send messages or regulate systems in the body, often in ways that scientists don’t fully understand. Researchers have known about some peptides for decades, and dozens have been turned into safe and effective drugs. The hormone insulin is a peptide that moves sugar from the bloodstream into cells; GLP-1, or glucagon-like peptide-1, spurs the pancreas to release insulin and slows the passage of food through the gut. (Peptides are usually defined as having about fifty amino acids or fewer; more than that and they’re proteins.) But the science underpinning the current peptide craze dates to the turn of the century, when Pinchas Cohen, a respected pediatric endocrinologist at the University of California, Los Angeles, started to focus on age-related diseases. For one project, Cohen tried to disrupt a protein associated with insulin resistance and diabetes. By injecting human DNA into yeast cells, he was able to produce several chains of amino acids that clung to his target. Cohen told me that the first two chains were known proteins, but the third was “this ridiculous little thing” made up of only twenty-four amino acids. Strangely, he couldn’t figure out where it had come from. According to the conventional wisdom of the day, the DNA he’d injected shouldn’t have coded for it.

人体能产生数千种肽。其中许多是蛋白质片段,它们以科学家尚未完全理解的方式传递信息或调节身体系统。研究人员对某些肽的了解已有数十年,其中数十种已被制成安全有效的药物。激素胰岛素是一种肽,能将血糖从血液转移到细胞中;胰高血糖素样肽-1(GLP-1)能刺激胰腺释放胰岛素并减缓食物通过肠道的速度。(肽通常被定义为约含五十个或更少氨基酸;超过这个数量则称为蛋白质。)但当前肽热潮背后的科学原理可追溯到世纪之交,当时加州大学洛杉矶分校备受尊敬的儿科内分泌学家皮恩查斯·科恩(Pinchas Cohen)开始专注于与年龄相关的疾病。在一个项目中,科恩试图干扰一种与胰岛素抵抗和糖尿病相关的蛋白质。通过将人类DNA注入酵母细胞,他成功产生了几个能附着在目标蛋白质上的氨基酸链。科恩告诉我,前两条链是已知蛋白质,但第三条是“这个可笑的小东西”,仅由二十四个氨基酸组成。奇怪的是,他无法确定它的来源。按照当时的传统认知,他注入的DNA本不该编码出这种肽。
Two aliens in spaceship abducting a flower.
“Ever since you gave up abducting humans, you seem happier.”
“自从你放弃绑架人类之后,你看起来开心多了。”
Cartoon by P. C. Vey
Copy link to cartoon
Shop

The peptide, humanin, was ultimately traced to a tiny snippet of mitochondrial DNA—part of the ninety-eight per cent of the human genome that had long been dismissed as “junk DNA.” Cohen’s work helped reveal that, in the three-billion-letter book that is our genome, even obscure one-liners can be an important part of the story. Junk DNA, it turned out, wasn’t junk: it contains instructions for numerous peptides and proteins that had never been studied. “The public conception of peptides doesn’t grasp what’s going on from a scientific perspective,” Cohen told me. “This is not a dozen or so things you can buy at the gym. This is a revolution in science. It’s going to start a new era of drug discovery.”

这种名为“人类素”(humanin)的多肽,最终被追溯至线粒体DNA的一个微小片段——它属于人类基因组中那百分之九十八曾被长期视为“垃圾DNA”的部分。科恩的研究帮助揭示,在我们基因组这本长达三十亿字母的巨著中,即使晦涩的单行片段也可能是故事的重要篇章。事实证明,垃圾DNA并非垃圾:它包含着大量从未被研究过的多肽与蛋白质的编码指令。“公众对多肽的认知未能从科学视角把握正在发生的变革,”科恩告诉我,“这不是你在健身房能买到的十几种补剂。这是科学界的革命,将开启药物研发的新纪元。”

Cohen had little control over how his groundbreaking research would be used, however. After he published a series of animal and cell studies on humanin’s potential benefits—the peptide seemed to curb inflammation, control glucose, and possibly even provide protection against Alzheimer’s—so-called biohackers began ordering it on the gray market. Cohen himself tried to develop it as a drug, but the peptide was so unstable that it broke down within minutes. More concerning, humanin was eventually linked to breast and brain cancers. Nonetheless, it continued to be sold online. Koniver told me that he has taken it. “I have no idea what people are injecting,” Cohen said. “Probably fragments of degraded material.”

然而,科恩对自己这项开创性研究将如何被应用几乎无能为力。在他发表一系列关于人类肽(humanin)潜在益处的动物与细胞研究后——这种肽似乎能抑制炎症、控制血糖,甚至可能预防阿尔茨海默病——所谓的“生物黑客”们便开始在灰色市场上订购它。科恩本人曾尝试将其开发成药物,但这种肽极不稳定,几分钟内就会分解。更令人担忧的是,人类肽后来被发现与乳腺癌和脑癌有关联。尽管如此,它仍在网上持续销售。科尼弗告诉我他服用过这种物质。“我完全不知道人们注射的是什么,”科恩说,“很可能是降解物质的碎片。”

Cohen is now the dean of the gerontology school at the University of Southern California, and his lab has identified many more peptides. “The rule in my lab is, if you discover it, you get to name it—but I have veto power,” he told me. “I like Yiddish names.” SHLP stands for “small humanin-like peptide”; SHMOOSE stands for “small human mitochondrial ORF over serine tRNA.” Other discoveries include MENTSH and PUTZ. His team is best known for identifying MOTS-c, which has been called an exercise mimetic: it activates cellular pathways that are usually turned on during exercise. Strikingly, older mice treated with the peptide can run for twice as long as their untreated counterparts.

科恩现在是南加州大学老年学学院的院长,他的实验室已经发现了更多肽类物质。“我实验室的规矩是,谁发现了它,谁就有命名权——但我有一票否决权,”他告诉我,“我喜欢意第绪语的名字。”SHLP代表“小型类人源肽”;SHMOOSE代表“丝氨酸tRNA上的小型人类线粒体开放阅读框”。其他发现还包括MENTSH和PUTZ。他的团队最著名的是发现了MOTS-c,这种物质被称为运动模拟物:它能激活通常在运动期间启动的细胞通路。引人注目的是,用这种肽治疗的年老小鼠,其奔跑时长可达未经治疗小鼠的两倍。

Cohen deemed MOTS-c promising enough that he founded a company to take it into a Phase I clinical trial—an early step on the road toward F.D.A. approval. The peptide caused skin irritation but otherwise appeared to be safe. Its short half-life, however, required it to be injected several times a day, which limited its appeal as a drug, and the company ran out of funding. MOTS-c is now on the F.D.A.’s do-not-compound list, owing to the potential risk of immune reactions “for certain routes of administration.” Yet it, too, continues to circulate on the gray market. One Redditor said that, since he started taking it, “energy and stamina are through the roof.” Cohen reacts to these trends with dismay. As enthusiastic as he is about the potential of peptides, he told me, “people should not be taking them until they’re fully tested. The history of shortcuts is not a happy one.”

科恩认为MOTS-c前景看好,于是成立了一家公司,将其推进一期临床试验——这是通往美国食品药品监督管理局(FDA)批准之路的早期步骤。这种肽类物质会引起皮肤刺激,但除此之外似乎安全。然而,其半衰期过短,需要每日多次注射,这限制了它作为药物的吸引力,公司也因此耗尽资金。由于“某些给药途径”存在潜在的免疫反应风险,MOTS-c现已被列入FDA的“禁止复配药物清单”。但它仍在灰色市场上流通。一位Reddit用户表示,自从开始服用后,“精力和耐力都冲破了天花板”。面对这些现象,科恩感到忧心忡忡。尽管他对肽类物质的潜力充满热情,但他告诉我:“在完成全面测试之前,人们不应该服用它们。走捷径的历史从来都不令人愉快。”

The evidence in favor of many other unapproved peptides is even sparser. BPC-157, which is short for Body Protection Compound 157, was discovered in human gastric juice in a lab led by Predrag Sikiric, a Croatian scientist. (It appears to be a fragment of a larger gastric protein, but no one has traced it to a human gene; Cohen thinks it’s probably a product of bacteria that live in the gut.) Studies have touted a staggering variety of benefits in cells and animals; it reportedly heals ulcers, regenerates nerves, aids muscle and tendon repair, counters neurodegenerative diseases, and protects organs from injuries. But most of this research is co-authored by Sikiric, who holds several patents related to BPC-157, and some experts have accused him of cherry-picking evidence. “Science advances through critical verification rather than by repeatedly affirming findings within the same research group,” a team of scientists in Poland wrote in response to Sikiric’s BPC157 claims. In the usual course of things, a promising drug candidate would be ushered into human trials. Yet, in the three-plus decades since BPC-157 was discovered, no controlled human trial of the peptide has ever been published. In the nineties, Sikiric licensed the compound to a Croatian company called Pliva, which sought a treatment for ulcerative colitis; the results were never released. In 2006, the research-and-development arm of Pliva was acquired by GlaxoSmithKline, which has ample resources for clinical trials, but the company has not commercialized the peptide. According to Sara Talpos of the science magazine Undark, a company partly owned by Sikiric sponsored a 2015 trial, at a hospital in Tijuana, that tested the safety of an oral version of BPC-157. The results still haven’t been published. Sikiric assured me that the trial had been “absolutely successful” and that the data would be available “very soon,” but he declined to let me see it.

其他许多未经批准的肽类药物的证据更为稀少。BPC-157(全称“机体保护化合物157”)由克罗地亚科学家普雷德拉格·西基里奇(Predrag Sikiric)领导的实验室在人类胃液中发现。(它似乎是某种胃蛋白的片段,但尚未被追溯到人类基因;科恩认为它很可能是肠道细菌的产物。)各类研究吹捧其在细胞和动物实验中展现出惊人的多重功效:据报道能愈合溃疡、再生神经、促进肌肉肌腱修复、对抗神经退行性疾病、保护器官免受损伤。但大多数研究都由西基里奇共同署名——他持有数项与BPC-157相关的专利,部分专家指责其选择性使用证据。“科学进步依靠的是批判性验证,而非同一研究团队反复确认研究结果,”波兰科学家团队曾针对西基里奇的BPC-157主张如此回应。按照常规流程,有潜力的候选药物应进入人体试验阶段。然而自BPC-157被发现三十余年来,从未有任何关于该肽类药物的对照人体试验结果发表。九十年代,西基里奇将该化合物授权给克罗地亚制药公司普利瓦(Pliva),后者试图开发溃疡性结肠炎疗法,但试验结果始终未公开。2006年,葛兰素史克收购了普利瓦的研发部门,这家巨头本拥有充足的临床试验资源,却未将该肽类药物商业化。据科学杂志《暗物质》(Undark)记者萨拉·塔尔波斯(Sara Talpos)披露,西基里奇部分持股的公司曾在2015年于蒂华纳某医院赞助过口服版BPC-157的安全性试验,结果至今未见刊发。西基里奇向我保证试验“绝对成功”,数据将“很快”公布,但拒绝让我查看。

Independent scientists have said that BPC-157 appears promising in lab studies—but with major caveats. The peptide seems to stimulate the production of nitric oxide, which enhances blood flow and reduces certain forms of inflammation, but it also generates free radicals that damage DNA and proteins. In addition, the peptide seems to promote angiogenesis, the development of new blood vessels, possibly via a signalling molecule expressed in many human cancers. “You don’t want to just willy-nilly stimulate angiogenesis,” Paul Knoepfler, a biologist at the University of California, Davis, School of Medicine, told me. (Sikiric argues that it does these things in a balanced way; he has written that, when it comes to nitric oxide and angiogenesis, “all criticisms of BPC 157 should be dismissed.”)

独立科学家们表示,实验室研究显示BPC-157肽段前景可观——但存在重大限制。这种肽似乎能刺激一氧化氮生成,从而促进血流并抑制某些炎症反应,但同时也会产生损伤DNA与蛋白质的自由基。此外,该肽段可能通过人类多种癌症中表达的信号分子,促进血管生成(即新血管的形成)。“我们绝不能随意刺激血管生成,”加州大学戴维斯分校医学院生物学家保罗·克内普夫勒(Paul Knoepfler)告诉我。(西基里奇则主张该肽段以平衡方式发挥作用;他曾撰文指出,关于一氧化氮与血管生成的争议中,“所有对BPC 157的批评都应被驳回”。)

At the inaugural MAHA summit, last year, a compounding-pharmacy executive told the audience that his grandmother was taking BPC-157, and that this was “just one example of these products that can change people’s lives.” Andrew Huberman said on a podcast that two shots had healed a back injury, even as he warned listeners about the peptide’s potential risks. In online forums, people have credited the peptide with boosting energy and curbing pain; they have also reported strange rashes, increased fatigue, depressed moods, and vision problems. It’s possible that BPC-157 is useful, and that the potential gains are worth the potential pains. But, absent human trials, it’s next to impossible to know what it does in the body. Some health consequences might not become apparent for years—and anecdotal evidence is rife with confounding factors. If a peptide stack is popular among weight lifters, who’s to say which peptide did what? Maybe the perceived benefits are actually attributable to dead lifts, or protein shakes, or a good night’s sleep. Knoepfler warned of placebo effects. When people think a medicine is pricey, they frequently report benefits, even when it’s actually an inert substance. “You pay all this money,” Knoepfler said. “You get a set of vials. You inject yourself. It hurts. You really want this to work.”

在去年的首届MAHA峰会上,一位复合药房高管告诉听众,他的祖母正在服用BPC-157,并称这“只是这些能改变人们生活的产品的一个例子”。安德鲁·胡伯曼在播客中说,两针就治好了他的背部损伤,尽管他也警告听众这种肽的潜在风险。在在线论坛上,人们称赞这种肽能提升精力、抑制疼痛;也有人报告出现奇怪的皮疹、疲劳加剧、情绪低落和视力问题。BPC-157可能确实有用,潜在的收益或许值得冒这些风险。但在缺乏人体试验的情况下,几乎不可能知道它在体内到底起什么作用。有些健康影响可能多年后才会显现——而坊间证据充满了混杂因素。如果某种肽组合在举重运动员中很流行,谁能说清是哪种肽起了什么作用?也许感知到的好处实际上归功于硬拉、蛋白奶昔,或者一夜好眠。克内普夫勒警告过安慰剂效应。当人们认为某种药物价格昂贵时,即使它实际上是惰性物质,他们也经常会报告益处。“你花了这么多钱,”克内普夫勒说,“拿到一套小瓶。给自己注射。会疼。你真的很希望这能奏效。”

In some cases, peptides have been clearly linked to harms. Last year, at the Revolution Against Aging and Death Festival, in Las Vegas, two women received peptide injections at a conference booth; shortly thereafter, they developed elevated heart rates, swollen tongues, and trouble breathing. By the time they reached the hospital, one of them had lost control of her neck muscles, and the other had been intubated. Both were ultimately connected to ventilators. (The peptides involved have not been disclosed.) The doctor who administered the injections defended himself by citing an A.I.-generated report, telling ProPublica that it “basically says that it is impossible it was the peptides.” When I asked Sikiric whether people should be using peptides like BPC-157, given the lack of data in humans, he said, “As a medical doctor, I should reply negatively. As a human person, I’m not sure. You have to do what’s right for you.” Regulatory agencies have a role to play, he said, but “the final judgment of whether something works belongs to the people, not the F.D.A.”

在某些情况下,肽类物质已被明确证实会造成伤害。去年在拉斯维加斯举行的“抗衰老抗死亡革命节”上,两名女性在会议展位接受了肽类注射;此后不久,她们便出现心率加快、舌头肿胀和呼吸困难等症状。被送往医院时,其中一人已丧失颈部肌肉控制能力,另一人则被插管。两人最终都接上了呼吸机。(所涉肽类物质的具体成分尚未披露。)实施注射的医生引用一份人工智能生成的报告为自己辩护,他对ProPublica表示该报告“基本上说明不可能是肽类物质导致的问题”。当我询问西基里奇(Sikiric),鉴于缺乏人体数据,人们是否应该使用BPC-157这类肽类物质时,他答道:“作为医生,我理应给出否定回答。但作为普通人,我不确定。每个人都必须为自己做出正确的选择。”他表示监管机构固然有其职责,但“最终判断某种物质是否有效的权力属于民众,而非美国食品药品监督管理局。”

Let’s say you want to make money on health-related products without feeling the squeeze of F.D.A. regulations. You have two main options, Peter Lurie, a former F.D.A. official who now leads the Center for Science in the Public Interest, told me. The first is to adopt a clever marketing strategy. If your company were to claim that its product treats COVID, it would be selling a drug. “Boom! The F.D.A. can come down on you,” Lurie said. But, if the company describes its product as an immunity booster, the agency’s authority is less clear. You usually don’t need to conduct clinical trials to sell dietary supplements, sometimes referred to as “nutraceuticals.”

假设你想在健康产品上赚钱,又不想受美国食品药品监督管理局(FDA)的监管压力。前FDA官员、现任公共利益科学中心负责人的彼得·卢里告诉我,你主要有两种选择。第一种是采取巧妙的营销策略。如果你的公司声称其产品能治疗新冠,那它就是在销售药品。“砰!FDA就能找上门来,”卢里说。但如果公司将产品描述为“免疫增强剂”,监管机构的管辖权就不那么明确了。销售通常被称为“营养保健品”的膳食补充剂,通常不需要进行临床试验。

A second loophole involves compounding pharmacies, which are largely regulated by state pharmacy boards. Sam An, a pharmacist at a compounding pharmacy until 2021, told me that his workplace employed about twenty people—pharmacists, technicians, cashiers, couriers—in what resembled a chemistry laboratory. At first, he said, “I felt like I was making a difference.” He might create a liquid drug for someone who couldn’t swallow pills or a fertility drug tailored to a woman’s hormone levels. With time, though, An grew disillusioned. For many such pharmacies, he said, “it seemed like the focus became how to make a quick buck.” During the pandemic, compounders charged exorbitant prices for ivermectin, even after the drug proved ineffective against COVID-19. Many started profiting from GLP-1 drugs during widespread shortages. “They’ll add a vitamin and say, ‘Look, we’ve customized it for you,’ with a wink and a nod,” An said. “The barriers to doing these things are laughable.” He considers the peptide craze even more troubling. “They’re taking advantage of a population that’s looking for a solution and charging them lots of money for something with no proven benefit that could potentially cause harm,” he continued. “How is that O.K.?”

第二个漏洞涉及复合药房,这类机构主要由州药房委员会监管。曾在复合药房担任药剂师直至2021年的山姆·安(Sam An)告诉我,他工作的地方约有二十名员工——药剂师、技术员、收银员、快递员——环境类似化学实验室。他说起初“我觉得自己在创造价值”。他可能为无法吞咽药片的人配制液体药物,或根据女性激素水平定制助孕药物。但随着时间的推移,安逐渐感到幻灭。他说对许多这类药房而言,“重点似乎变成了如何快速赚钱”。疫情期间,复合药房对伊维菌素收取天价,即便该药已被证实对新冠肺炎无效。在GLP-1药物普遍短缺期间,许多药房开始从中牟利。“他们会添加维生素然后眨眨眼说'看,我们为您定制了药物'”安说道,“做这些事的门槛低得可笑。”他认为多肽热潮更令人不安。“他们利用寻找解决方案的人群,收取高额费用提供未经证实疗效且可能有害的产品,”他继续说道,“这怎么能被允许呢?”

The F.D.A. began taking a more assertive approach in 2012, when steroids from a Massachusetts compounding pharmacy led to hundreds of cases of meningitis and more than sixty deaths. “The agency is well aware that there’s plenty of activity out there that is likely illegal,” Lurie told me. But the F.D.A., like the I.R.S., has the resources to go after only a fraction of serious violations. “By the time you put BPC-157 on the list, there’s probably a BPC-158,” Lurie said. (“There has not been a ‘war on peptides,’ ” he added. “There has been a war on unapproved products making improper claims.”) Trump’s F.D.A., which reports to Kennedy, is also unlikely to aggressively enforce restrictions on peptides. Neither H.H.S. nor the F.D.A. responded to requests for interviews with Kennedy or Marty Makary, the F.D.A. commissioner. A request to speak with a top F.D.A. compliance official was met with a boilerplate statement that said, in part, “Americans deserve to know the quality of the products they are buying and deserve drugs that have been proven to be safe and effective.”

美国食品药品监督管理局(F.D.A.)在2012年开始采取更强硬的监管立场,当时马萨诸塞州一家复方药房生产的类固醇药物导致数百例脑膜炎感染和六十多人死亡。“该机构非常清楚,市面上存在大量可能非法的经营活动,”卢里告诉我。但和国税局(I.R.S.)一样,食药监局只能追查一小部分严重违规行为。“等到你把BPC-157列入监管清单时,可能已经出现了BPC-158,”卢里说。(他补充道:“并不存在所谓的'肽类战争',我们打击的是那些未经批准却进行不当宣传的产品。”)向肯尼迪汇报工作的特朗普政府时期的食药监局,也不太可能积极执行对肽类物质的限制措施。卫生与公众服务部(H.H.S.)和食药监局均未回应关于采访肯尼迪或食药监局局长马蒂·马卡里的请求。当提出采访食药监局高级合规官员时,得到的是一份模板声明,其中部分内容写道:“美国民众有权知晓所购产品的质量,并应获得已被证明安全有效的药物。”

Fans of peptides are increasingly cutting out the middleman and ordering directly from gray-market suppliers. Last year, a twentysomething man I’ll call Michael, who regularly lifts weights and practices jiujitsu, began struggling with fatigue and weight gain after starting a new job and recovering from a bad bout of COVID. Friends of his had taken peptides—he remembers one of them telling him, “Bro, you should really try them out”—but Michael was initially wary. He spent weeks reviewing animal studies and reading testimonials on various online forums. He ultimately decided to order some retatrutide—an experimental GLP-1 drug that Eli Lilly has advanced to Phase III clinical trials—from a company that sells chemicals for research. He received a container of powder, mixed it with water, and injected it into his stomach. He felt so nervous that he almost passed out. But he soon lost weight, and that made him curious about what other peptides could do.

肽类产品的拥趸们正越来越多地绕过中间商,直接向灰色市场供应商下单。去年,一位二十多岁的年轻人——姑且称他为迈克尔——开始出现疲劳和体重增加的问题,当时他刚换了新工作,又刚从一场严重的新冠感染中恢复过来。迈克尔平时经常举重,还练习柔术。他的朋友们都服用过肽类产品——他记得其中一人曾对他说:“兄弟,你真该试试。”但迈克尔起初持谨慎态度。他花了数周时间查阅动物研究资料,浏览各大网络论坛上的用户反馈。最终,他决定从一家销售研究用化学品的公司订购一些瑞塔鲁肽(retatrutide)——这是礼来公司已推进至三期临床试验的一种实验性GLP-1药物。收到粉末容器后,他用水将其混合,注射进自己的腹部。他紧张得几乎昏厥。但体重很快开始下降,这让他对其他肽类产品能产生什么效果产生了好奇。

Michael had a nagging foot injury, possibly related to jiujitsu, so he ordered a stack of supposedly healing peptides known as the KLOW blend, which includes KPV, GHK-Cu, TB-500, and BPC-157. “You pretty much use the general consensus of what people have taken before you,” Michael told me. (Luke Turnock, a sociologist at the University of Lincoln, in England, has described this phenomenon as “folk pharmacology.”) Michael’s foot pain improved, but, strangely, he also noticed that his skin was changing color; KPV derives from a hormone that contributes to skin pigmentation. Next, Michael ordered a peptide called Semax, which, in Russian, is short for “seven amino acids.” In parts of Eastern Europe, Semax is prescribed for brain trauma and other neurological conditions. “People use it kind of like an Adderall,” Michael told me. Although he found himself procrastinating less, he started to feel “like a pincushion,” he said. He decided to save it for “when I felt like I really needed it.”

迈克尔脚上有处旧伤,可能是柔术训练留下的,于是他订购了一堆据说有疗效的肽类物质,即KLOW混合剂,内含KPV、GHK-Cu、TB-500和BPC-157。“你基本上就是参考前人的用药经验,”迈克尔告诉我。(英国林肯大学的社会学家卢克·特诺克将这种现象称为“民间药理学”。)迈克尔的脚痛有所缓解,但奇怪的是,他注意到自己的肤色也在改变;KPV源自一种影响皮肤色素的激素。接着,迈克尔又订购了一种名为Semax的肽,在俄语里是“七种氨基酸”的缩写。在东欧部分地区,Semax被用于治疗脑损伤和其他神经系统疾病。“人们用它就像用阿得拉一样,”迈克尔告诉我。虽然他发现自己拖延症有所减轻,但开始感觉“自己像个针垫”。他决定把这种药留到“真正需要的时候再用”。

Finally, Michael began taking MOTS-c. He said to himself, “O.K., if my mitochondria got fucked up in some way from COVID, hopefully this fixes the system.” The peptide seemed to give him more energy, but he noticed that he was sweating a lot. When I asked Michael if he felt uncomfortable putting untested products into his body, he, too, invoked COVID shots, calling them “a vaccine that also had no long-term studies.” “So it’s, like, Pick your poison,” he said. If the health-care system fails to meet the needs of patients, people will look for their own solutions. “This stuff is going to get a lot more popular,” he told me.

最终,迈克尔开始服用MOTS-c。他对自己说:“好吧,如果新冠病毒以某种方式破坏了我的线粒体,希望这个能修复系统。”这种肽似乎让他精力更充沛,但他注意到自己出汗很多。当我问迈克尔是否对将未经测试的产品注入体内感到不安时,他也提到了新冠疫苗,称其为“同样没有长期研究的疫苗”。“所以这就像是在选择毒药,”他说。如果医疗系统无法满足患者的需求,人们就会寻找自己的解决方案。“这类东西会越来越受欢迎,”他告诉我。

I decided to procure some peptides of my own. Michael recommended a company called SwissChems. “It’s legit,” he said, not one of those “trust-me-bro situations.” A quick search told me that, in 2024, the F.D.A. sent the company a warning letter that said, in part, “Despite statements . . . marketing your products as ‘research chemicals only,’ evidence obtained from your website establishes that your products are intended to be drugs for human use.” I spent a hundred and seven dollars on some BPC-157, CJC1295, and TB-500. At checkout, thirty capsules of demoxytocin—a synthetic hormone that doctors use to induce labor and to treat postpartum bleeding—were added to my cart for free, as though they were lotion samples from Kiehl’s.

我决定也给自己弄点肽。迈克尔推荐了一家叫SwissChems的公司。“这家靠谱,”他说,不是那种“信我准没错”的野路子。简单搜索后我发现,2024年美国食品药品监督管理局曾向该公司发出警告信,其中提到:“尽管贵公司声明……将产品宣传为'仅供研究用化学品',但从贵网站获取的证据表明,这些产品实为供人使用的药物。”我花了一百零七美元买了些BPC-157、CJC1295和TB-500。结账时,三十粒地莫催产素——一种医生用来引产和治疗产后出血的合成激素——被免费加入购物车,仿佛只是科颜氏派发的乳液小样。

I ordered three hundred dollars of MOTS-c from the Ultimate Human, a website run by Gary Brecka, a prominent biohacker who has hosted R.F.K., Jr., on his podcast. In my cart, a photograph showed a futuristic blue vial labelled with the words “Research use only,” yet an order of bacteriostatic water and syringes was automatically included, and I was asked to fill out a questionnaire and meet with a medical provider. A video chat with someone named Cynthia appeared on the screen. “You did great with your answers, so I’ll approve it,” she told me. The consultation lasted less than thirty seconds.

我从“终极人类”网站订购了价值三百美元的MOTS-c肽。该网站由知名生物黑客加里·布雷卡运营,他曾在小罗伯特·肯尼迪的播客节目中担任嘉宾。购物车页面显示着一个未来感十足的蓝色小瓶照片,标签上印着“仅供研究使用”字样,但系统却自动加入了抑菌水和注射器的订单,并要求我填写问卷并与医疗人员会面。屏幕上随即弹出了与一位名叫辛西娅的医疗人员的视频通话窗口。“您的回答很完美,我这就批准订单,”她告诉我。整个问诊过程持续了不到三十秒。

Finally, I searched for peptides on TikTok. On a page called Peptide Nexus, which had more than ten thousand followers, I watched animated vials of personified peptides that looked like the emotion avatars in the movie “Inside Out.” “Yo, I’m TB-500!” a smirking red vial declared, a fire raging in the background. “I’m the recovery peptide people call Wolverine mode.” A vial labelled PT-141, which is marketed as a treatment for low libido, was depicted in a tuxedo, shooting a Cupid’s arrow. “I target desire pathways,” it said. “People call me the date-night peptide.” When I submitted an inquiry on WhatsApp, the vender responded with a guarantee of “99% purity.” I made a few selections from a PDF menu. Most payment platforms will flag peptide sales, the vender said, and sent me a video explaining how to pay in cryptocurrency. My bank initially flagged the transaction as concerning; I had to give my assurance that I really did want to convert a hundred and eighty-five dollars into bitcoin.

最后,我在TikTok上搜索了肽类产品。一个名为“肽链枢纽”的账号拥有上万粉丝,页面里充斥着拟人化的动画肽瓶——它们看起来就像电影《头脑特工队》里的情绪小人。“哟,我是TB-500!”一个咧着嘴笑的红色药瓶宣称,背景里火焰熊熊燃烧,“我就是那个被称作'金刚狼模式'的恢复肽。”而标着PT-141(这种肽被宣传为治疗性欲低下的药物)的药瓶则穿着燕尾服,射出丘比特之箭。“我专攻欲望通路,”它说道,“人们叫我'约会之夜肽'。”当我在WhatsApp上咨询时,卖家回复保证“纯度99%”。我从一份PDF目录中挑选了几款产品。卖家表示大多数支付平台都会标记肽类交易,随后发来一段视频教我如何用加密货币付款。我的银行起初将这笔交易标记为可疑操作;我不得不反复确认自己确实想把185美元兑换成比特币。

The idea of medical freedom—that we should be allowed to decide what to do about our own health—has long had a special status in the United States. “A significant portion of Americans have embraced freedom of therapeutic choice as a constitutional value for most of the country’s history,” Lewis Grossman, a medical historian, writes in his book “Choose Your Medicine.” Benjamin Rush, a Founding Father and a physician, criticized the medical establishment for being closed-minded about treatments recommended by non-physicians. “Many of our most useful remedies have been discovered by quacks,” he argued. In the late nineteenth century, the psychologist and philosopher William James wrote, “If the word ‘sacred’ can be applied to any personal right, surely the right to treat one’s own body as one chooses may claim this title.” A few years later, the Postmaster General stopped delivering mail to the American School of Magnetic Healing, arguing that the organization was committing medical fraud. The school sued, contending that its methods were legitimate, and the Supreme Court ultimately ruled in its favor. “There is no exact standard of absolute truth by which to prove the assertion false and a fraud,” the majority opinion said.

医疗自由——即我们应有权决定如何处置自己的健康——这一理念在美国历来享有特殊地位。“在美国历史的大部分时期,相当一部分美国人已将治疗选择自由视为宪法价值,”医学史学者刘易斯·格罗斯曼(Lewis Grossman)在其著作《选择你的药物》中写道。开国元勋兼医师本杰明·拉什(Benjamin Rush)曾批评医疗体系对非医师推荐的治疗方案抱持封闭态度,他主张:“我们许多最有效的疗法都是由江湖医生发现的。”十九世纪末,心理学家兼哲学家威廉·詹姆斯(William James)写道:“若'神圣'一词可用于任何个人权利,那么按自己意愿处置身体的权利无疑当得起这个称号。”数年后,美国邮政总局局长停止向美国磁疗学校投递邮件,指控该机构实施医疗欺诈。该校提起诉讼,坚称其疗法正当合法,最终最高法院作出了有利于该校的判决。多数意见书指出:“不存在绝对的真理标准来证明其主张虚假欺诈。”

In the twentieth century, however, scandals involving unregulated medical products helped swing the balance of power toward regulation. In the thirties, elixir sulfanilamide, an antibiotic mixed into a toxic solvent, gave patients intense pain, kidney failure, and neurological problems. After more than a hundred people, including many children, died across fifteen states, Congress passed the Federal Food, Drug, and Cosmetic Act of 1938, which authorized the F.D.A. to evaluate a medical product’s safety before it could be sold. The agency’s modern-day role was defined in 1962, after thalidomide caused birth defects in thousands of babies around the world. The Act was amended to include a much higher standard: drugmakers now needed to conduct controlled trials in order to demonstrate that their products were effective. The gap between the two standards was immense. Around two-thirds of drugs that met the 1938 safety requirement failed the 1962 efficacy bar.

然而,二十世纪几起涉及未受监管的医疗产品的丑闻,彻底改变了监管权力的天平。三十年代,一种混入有毒溶剂的抗生素“磺胺酏剂”导致患者剧痛、肾衰竭和神经系统损伤。当超过一百人(包括许多儿童)在十五个州相继死亡后,国会于1938年通过了《联邦食品、药品和化妆品法案》,授权美国食品药品监督管理局(F.D.A.)在医疗产品上市前评估其安全性。该机构的现代职能则是在1962年确立的——当时沙利度胺导致全球数千名婴儿先天畸形。法案修订后设立了更高的标准:制药商必须通过对照试验证明其产品有效性。这两项标准间的鸿沟是巨大的。约三分之二符合1938年安全要求的药物,都未能通过1962年的有效性门槛。

It is becoming possible to imagine a future in which American regulators lose their grip on the safety and the efficacy of drugs. The venture capitalist Jim O’Neill, Trump’s former acting director of the Centers for Disease Control and Prevention and the current nominee to lead the National Science Foundation, has said that, as soon as drugs are proved to be safe, Americans should be able to “start using them at their own risk. . . . Let’s prove efficacy after they’ve been legalized.” Most states have enacted so-called right-to-try laws, which enable patients with life-threatening diagnoses to receive treatments that have completed Phase I safety testing. (More than ninety per cent of such treatments will not be F.D.A.-approved.) In recent years, Montana state laws have gone even further, granting all patients access to an even wider array of experimental treatments. The state may become a hub for medical tourism. Clinicians are shielded from many kinds of disciplinary action, and they can practice for up to twenty-one days a year without holding a Montana medical license.

我们正逐渐能够想象这样一个未来:美国监管机构对药品安全性和有效性的把控将日渐松弛。风险投资家吉姆·奥尼尔(Jim O'Neill)——特朗普任内曾代理疾病控制与预防中心主任,现被提名为国家科学基金会负责人——曾公开表示,只要药物被证实安全,美国人就应该能“自主承担风险开始使用……待药物合法化后再验证其疗效”。目前全美大多数州已颁布所谓“尝试权法案”,允许被诊断罹患危及生命疾病的患者接受已完成一期安全性测试的治疗方案(其中超过九成的治疗方案尚未获得美国食品药品监督管理局批准)。近年来蒙大拿州的法律甚至走得更远,允许所有患者接触更广泛的实验性疗法。该州可能成为医疗旅游的新兴枢纽——临床医生可免受多种纪律处分,且每年无需持有蒙大拿州行医执照即可执业长达21天。

The case for more medical freedom rests on laudable principles. We don’t usually want the government deciding what we can and can’t do with our bodies. And, clearly, there are shortcomings to the current drug-approval process. Pharmaceutical companies must typically invest many years and hundreds of millions of dollars to win approval for a drug; partly for this reason, some promising treatments are never approved, and many arrive too late for people who urgently need them. The economist Alex Tabarrok has written that when an approved drug harms people there are front-page stories, but “when the FDA fails to approve a good drug . . . the bodies are buried in an invisible graveyard.” On the other hand, if we’re making medical decisions in an information vacuum, are we really choosing freely? “The through line of history is that people will try to sell anything with all sorts of fantastical claims,” Joshua Sharfstein, a health-policy professor at Johns Hopkins and a former principal deputy commissioner of the F.D.A., told me. “If you’re for patient choice, you should be for a system that requires companies to show that their product does what they say it does.”

主张扩大医疗自由的理由,其原则值得称道。我们通常不希望政府决定我们能对自己的身体做什么、不能做什么。而且,当前的药物审批流程显然存在缺陷。制药公司通常必须投入多年时间和数亿美元才能获得药物批准;部分由于这个原因,一些有前景的治疗方法从未获批,许多药物对急需的患者来说来得太迟。经济学家亚历克斯·塔巴罗克(Alex Tabarrok)曾写道,当获批药物伤害患者时,会成为头版新闻,但“当FDA未能批准一种好药时……那些逝去的生命被埋葬在无形的墓园里。”另一方面,如果我们在信息真空中做出医疗决策,我们真的在自由选择吗?“历史的脉络是,人们会试图用各种奇幻的承诺来推销任何东西,”约翰斯·霍普金斯大学卫生政策教授、FDA前首席副专员约书亚·沙夫斯坦(Joshua Sharfstein)告诉我。“如果你支持患者选择权,你就应该支持一个要求企业证明其产品确实如其所言的体系。”

My first two peptide orders arrived quickly. The third, from Peptide Nexus, did not. A company that claimed to be handling the shipping process contacted me, saying that it wouldn’t send the peptides unless I paid a “refundable insurance fee”—another eighty-three dollars’ worth of bitcoin. The vender didn’t let me cancel my order, so I warily paid the fee. Two weeks later, neither the seller nor the shipper was responding to my messages, and I still had not received my order.

我订购的前两批肽很快就送到了。第三批来自肽链公司(Peptide Nexus)的货却迟迟未到。一家自称负责运输的公司联系了我,说除非我支付一笔“可退还的保险费”——价值八十三美元的比特币,否则不会发货。卖家不允许我取消订单,我只好惴惴不安地付了这笔钱。两周过去了,无论是卖家还是运输公司都不再回复我的消息,而我订购的货品依然不见踪影。

Reader, I did not inject myself with the peptides. Instead, I delivered them to Finnrick Analytics, a company in Austin, Texas, that tests powdered peptides for purity, potency, contaminants, and toxins. Results are posted on the company’s website, which gets more than a million hits a month. In the company’s telling, it is providing a public service—creating transparency and accountability where F.D.A. enforcement has fallen short or been stymied. “We test peptides to make sovereign health safer,” its website says. If you’re going to use, use safely. At the same time, insofar as the company promotes a kind of self-regulation within the peptide world, it also enhances the industry’s legitimacy. If a drug seems safer to take, maybe give it a try.

读者,我并没有给自己注射这些肽。相反,我把它们送到了位于得克萨斯州奥斯汀的芬瑞克分析公司——这家公司专门检测粉末状肽的纯度、效价、污染物和毒素。检测结果会发布在公司网站上,该网站每月访问量超过一百万次。按公司的说法,他们是在提供一项公共服务:在食品药品监督管理局执法不力或受阻的领域,创造透明度和问责机制。“我们检测肽,是为了让自主健康更安全,”其网站宣称。如果你打算使用,请安全使用。与此同时,尽管该公司在肽领域推动着某种自我监管,却也增强了这个行业的合法性。如果一种药物看起来更安全,或许值得一试。

Finnrick’s office is compact and sits on the second floor of a co-working space. On a filing cabinet, a fierce-looking figurine of Goku, the protagonist of the “Dragon Ball” manga franchise, appeared to be shooting a bottle of semaglutide out of his hands. On a table were scores of vials in trays; beneath it was a box stuffed with incoming packages. Jake Anderson, a recent college graduate, opens most of the packages, takes a photograph of the vials inside, and replaces the labels. “That’s so the lab doesn’t know where it’s coming from,” he said.

芬里克的办公室不大,位于一个联合办公空间的二楼。文件柜上摆着一个神情凶狠的《龙珠》主角孙悟空手办,仿佛正从手中射出一瓶司美格鲁肽。桌上托盘里放着几十个小药瓶,桌下则塞满待拆的包裹。刚大学毕业的杰克·安德森负责拆开大部分包裹,给里面的药瓶拍照,然后更换标签。“这样实验室就不知道药品来源了,”他解释道。

“We’ve been getting packages like mad men,” Caanan Towns, the company’s operations manager and a former college wrestler, said. He joined the company after using peptides to treat a hip injury. In the past year, the number of packages that Finnrick receives has increased more than fivefold, and since December it has more than doubled. “The crazy part is that we’ve put out zero marketing,” Towns added. “But peptides are like a hobby: people don’t just take peptides, they want to talk about them with their friends.”

“我们收包裹收到手软,”公司运营经理、前大学摔跤手卡南·汤斯(Caanan Towns)说。他因使用肽类治疗髋部损伤而加入这家公司。过去一年,芬尼克公司收到的包裹数量增长了五倍多,自去年十二月以来更是翻了一番还多。“最疯狂的是我们根本没做任何营销,”汤斯补充道,“但肽就像一种爱好:人们不只是自己用,还总想和朋友聊这个。”

Towns and I drove my peptide samples to a squat gray building about ten minutes away. Krause Analytical, a family-owned laboratory that Finnrick hires for much of its testing, also works with the F.D.A. to test food and pesticides that cross the Mexican border. I spotted a forklift and some sacks of corn flour inside. Mark Krause, the lab’s jovial, broad-shouldered director, walked me past dishwasher-size chromatography and mass-spectrometry machines. “Sometimes you don’t need all this fancy stuff to know something’s not right,” he told me. He held a vial of pale-blue powder in one hand and a vial of white powder in the other. “GHK-Copper should be blue,” he said. “If they send you something white, I don’t know what it is, but it ain’t GHK-Copper.”

我和汤斯开车,十分钟后抵达一栋低矮的灰色建筑。克劳斯分析实验室是家族经营的检测机构,芬尼克公司的许多检测项目都委托于此,该实验室同时也与美国食品药品监督管理局合作,检测从墨西哥边境入境的食品和农药。我在实验室里看到一辆叉车和几袋玉米粉。实验室主任马克·克劳斯(Mark Krause)肩膀宽阔,性格爽朗,他领我走过几台洗碗机大小的色谱仪和质谱仪。“有时候不需要这些高级设备也能看出不对劲。”他一手拿着装有淡蓝色粉末的样品瓶,另一手拿着白色粉末样品瓶说道,“GHK铜肽应该是蓝色的。如果他们寄来的是白色粉末,天知道那是什么,但肯定不是GHK铜肽。”
Snails stuck in car in traffic.
“This would’ve been faster on stomach.”
“这要是搁在胃里,早就到了。”
Cartoon by Amy Hwang
Copy link to cartoon
Shop

Krause, who seemed peptide-skeptical, estimated that about ten per cent of the peptides Finnrick sends him have serious anomalies of purity, dosage, or sterility. Some vials contain endotoxins—fragments of bacterial cell walls—suggesting poor manufacturing practices and a compromised supply chain. “But, hey, these are ‘research chemicals,’ right?” he said, winking. “Nobody’s injecting them into their bodies!” On a computer, Krause pulled up a chromatography analysis, which separates mixtures into individual components. The graph showed a flat line with a single sharp spike in the middle. “That’s pure,” Krause said, pointing to the spike. “Just one thing.” Next, he showed me a graph that looked like a jagged roller coaster. “All sorts of stuff in this one,” he said. “Or whatever was originally in there has degraded.” A third graph had two spikes—one for a known peptide called ipamorelin and another for something mysterious a few inches away. “We don’t know what that is,” Krause said.

克劳斯似乎对肽类产品持怀疑态度,他估计芬尼克寄来的肽类样品中约有百分之十存在纯度、剂量或无菌性方面的严重异常。有些小瓶中含有内毒素——细菌细胞壁的碎片——这表明生产工艺粗糙,供应链存在问题。“不过,嘿,这些可是'研究用化学品',对吧?”他眨眨眼说,“又没人把它们注射进身体里!”克劳斯在电脑上调出一份色谱分析图,这种技术能将混合物分离成单一组分。图表显示出一条平直的基线,中间有个尖锐的峰值。“这个很纯,”克劳斯指着峰值说,“只有一种成分。”接着,他给我看了一张形如锯齿状过山车的图表。“这里面什么都有,”他说,“也可能是原有成分已经降解。”第三张图表有两个峰值——一个是已知肽类伊帕莫林,另一个是几英寸外某种不明物质。“我们不知道那是什么,”克劳斯说。

About a week after my visit, Krause shared his analysis of the peptides I’d given him. According to his testing, my order of MOTS-c, from the Ultimate Human, was ninety-eight per cent pure and contained eighty-seven per cent of the dose on its label. (Of course, this didn’t mean that the peptide itself was safe or effective.) All the peptides I’d ordered from SwissChems had significant issues. The vial of BPC-157 contained lead, the vial of TB-500 contained endotoxins, and the vial of CJC-1295 contained less than forty-two per cent of the advertised dose.

在我拜访大约一周后,克劳斯分享了他对我提供的肽类物质的分析结果。根据他的检测,我从“终极人类”订购的MOTS-c纯度为百分之九十八,实际剂量为标签标示量的百分之八十七。(当然,这并不意味着该肽类物质本身安全有效。)而我从瑞士化学公司订购的所有肽类都存在严重问题:BPC-157小瓶中含有铅,TB-500小瓶中含有内毒素,CJC-1295的实际剂量不足标示量的百分之四十二。

Many of our era’s health trends have something in common: they strive not only to mitigate disease, as mainstream medicine has always been expected to do, but also to optimize health, an aim that many doctors shy away from. I’m not convinced I can offer unproven treatments and still uphold my oath to do no harm. And, even if I knew how to help people attain “peak performance” in their fitness, their careers, or their sex lives, I’m not sure that’s my job. If traditional doctors don’t promise their patients these things, however, others surely will. Timothy Caulfield, a law professor at the University of Alberta, said that health influencers increasingly engage in “scienceploitation”: they generate hype by making speculative claims that extrapolate wildly from limited research. “You take a genuinely exciting area of science and overstate and misrepresent it to sell bunk,” Caulfield said. In his view, Wellness 1.0—which focussed on alternative ways of knowing and on spirituality—has been replaced by Wellness 2.0, which often co-opts the language of science. “It’s almost too easy with peptides,” Caulfield told me. “Even just the word ‘peptides’ sounds science-y and legit.”

我们这个时代的许多健康潮流都有一个共同点:它们不仅致力于缓解疾病——主流医学向来被寄予这样的期望——还力求优化健康,而许多医生对此望而却步。我不确定自己能否在提供未经证实的疗法的同时,仍恪守“不伤害”的誓言。而且,即便我知道如何帮助人们在健身、事业或性生活中达到“巅峰状态”,我也不确定这是否属于我的职责范围。然而,如果传统医生不向患者承诺这些,其他人肯定会。阿尔伯塔大学法学教授蒂莫西·考菲尔德指出,健康领域的影响者正越来越多地参与“科学剥削”:他们通过从有限研究中过度推断出推测性主张来制造炒作。“他们选取真正激动人心的科学领域,夸大并歪曲事实来兜售伪科学。”考菲尔德认为,以另类认知方式和灵性为核心的“健康1.0”已被“健康2.0”取代,后者常常挪用科学话语。“用肽类物质做文章简直太容易了,”考菲尔德告诉我,“光是'肽'这个词听起来就很有科学感和正当性。”

On a rainy day this spring, I entered a large hotel in midtown Manhattan that was hosting the Integrative Health Symposium, an annual conference for “forward-thinking practitioners.” I walked through a buzzing exhibit hall, passing booths for “immunity-boosting” mushrooms and protein bars. For some reason, an online-prescribing company was raffling off a Louis Vuitton bag. I approached the booth of a compounding pharmacy and inquired about the peptide business. “The Feds don’t know what to do,” a representative told me. “It’s like Prohibition.”

今年春天一个下雨的日子,我走进曼哈顿中城一家大型酒店,这里正在举办“整合健康研讨会”,一个面向“前瞻性从业者”的年度会议。我穿过人声鼎沸的展厅,经过售卖“增强免疫力”蘑菇和蛋白棒的摊位。不知为何,一家在线处方公司正在抽奖赠送路易威登手袋。我走近一家复合药房的展位,询问有关肽类药物的业务。“联邦政府不知道该怎么办,”一位代表告诉我,“就像禁酒令时期一样。”

I was on my way to meet Edwin Lee, an Orlando-based endocrinologist who has worked to bolster the scientific credibility of unapproved peptides. Before I could locate him, a fit middle-aged man, who turned out to be a former car salesman, stopped me. “Want more energy and less pain?” he asked. He instructed me to stand on what looked like a futuristic skateboard—a “vibration plate” that purported to decrease stress, build muscle, increase circulation, and even improve sex. The board began to shake and flash purple; my whole body jiggled. “Get on this for ten minutes a day,” he said. “It’s the equivalent of being on an elliptical for an hour.” He was willing to sell me the board for half off a sticker price of thirty-six hundred dollars.

我正要去见埃德温·李(Edwin Lee),这位来自奥兰多的内分泌科医生一直致力于提升未经批准的肽类药物的科学可信度。还没等我找到他,一位身材健硕的中年男子——后来得知他曾是汽车销售员——拦住了我。“想精力更充沛、疼痛更少吗?”他问道。他让我站上一个看起来像未来主义滑板的东西——一块号称能减轻压力、增强肌肉、促进血液循环甚至改善性生活的“振动板”。板子开始震动并闪烁紫光;我的整个身体随之抖动。“每天站上去十分钟,”他说,“效果相当于在椭圆机上运动一小时。”他愿意以标价三千六百美元的一半价格把这板子卖给我。

I politely excused myself and found Lee in the hotel lounge. He was tall, with short salt-and-pepper hair, thin-rimmed glasses, and a happy-warrior disposition. Lee is known for having co-founded the Clinical Peptides Society, which offers a certification for people who want to administer peptides. He also started a petition called Save Peptides, which has collected nearly ten thousand signatures in an effort to loosen government restrictions. “A lot of conventional doctors think this is all bullshit,” he told me, smiling. “They think I’ve gone to the dark side. We agree to disagree, because I still want to go hiking with them.”

我礼貌地告退,在酒店休息室找到了李。他身材高大,灰白短发,戴着细框眼镜,一副乐天斗士的模样。李以共同创立临床肽学会而闻名,该机构为想要使用肽类制剂的人提供资质认证。他还发起了一项名为“拯救肽类”的请愿,已收集近万个签名,旨在推动政府放宽限制。“很多传统医生认为这都是胡扯,”他微笑着告诉我,“他们觉得我堕入了黑暗面。我们求同存异吧,毕竟我还想和他们一起徒步呢。”

A few years ago, Lee’s son, a high-school cross-country runner, developed a sharp pain down his leg. “Daddy can inject you with peptides,” Lee’s wife told him. The boy replied, “He’s not fucking injecting me!” Then Lee showed him some photographs that Sikiric, the Croatian peptide researcher, had published. They depicted a rat’s bloody Achilles tendon, which Sikiric’s team had cut into, healing after BPC-157 injections. Lee’s son ultimately acquiesced—“He just needed to see the evidence,” Lee said—and two weeks later he was running again. Lee now keeps peptides for his family in the butter compartment of his fridge.

几年前,李的儿子——一名高中越野跑选手——腿部出现剧烈疼痛。“爸爸可以给你注射肽,”李的妻子对儿子说。男孩回答:“他休想给我打针!”随后李向儿子展示了克罗地亚肽研究员西基里奇发表的一些照片。照片显示一只大鼠血淋淋的跟腱——西基里奇团队将其切断后——在注射BPC-157后愈合了。李的儿子最终同意了注射。“他只是需要看到证据,”李说。两周后,男孩又能跑步了。如今李将家人的肽存放在冰箱的黄油格里。

While we spoke, one of Lee’s patients, a health-care investor and a former soccer player, wandered into the lounge. One morning in 2024, the man had awoken with searing knee pain that turned out to be a meniscus tear. Several doctors had recommended that he get surgery. Then, at last year’s conference, he met Lee. “This random dude says he can fix you,” the man said. “Why do you trust him? Intuition. There’s something about him. I’ve never seen a doctor be that confident.” The man flew to Orlando, where Lee injected him with BPC-157. Within days, his knee pain improved.

我们交谈时,李的一位病人——一位医疗保健领域的投资人,曾经是足球运动员——溜达进了休息室。2024年的某个早晨,这人醒来时膝盖剧痛,后来确诊为半月板撕裂。好几位医生都建议他做手术。后来,他在去年的会议上遇到了李。“这个素不相识的家伙说他能治好你,”这人说,“凭什么相信他?直觉。他身上有种说不清的东西。我从没见过哪个医生能那么自信。”这人飞到奥兰多,李给他注射了BPC-157。几天之内,他的膝盖疼痛就减轻了。

“I don’t care how many publications someone has,” the man said, hopping on one leg for emphasis. “I don’t want studies. I want results.”

“我不管一个人发表了多少论文,”那人说着,单脚跳起以示强调,“我不要研究。我要结果。”

“Not everyone gets better that fast,” Lee said, beaming.

“不是每个人都能恢复得这么快,”李(Lee)笑着说道,脸上洋溢着喜悦。

Later, Lee and I both attended a talk on peptides by Steven A. R. Murphy, a Connecticut concierge doctor whose website advertises “telemedicine consultation and prescription for Rapamycin, Peptides and other medicines.” The room was so packed that some people were gathered outside the door. The title slide had a photo of a Ken doll with a syringe pointed at its forehead.

后来,我和李都去听了史蒂文·A·R·墨菲(Steven A. R. Murphy)关于肽类的讲座。墨菲是康涅狄格州的一位私人医生,他的网站宣传“提供雷帕霉素、肽类药物及其他药品的远程医疗咨询与处方服务”。会场挤得水泄不通,有些人甚至聚在门外。标题幻灯片上是一张肯娃娃的照片,一支注射器正对着它的额头。

“Which ones have you tried?” a young man standing next to me asked.

“你试过哪几款?”站在我身旁的一位年轻男子问道。

“None,” I said, feeling like a teetotaller in a frat house. He looked perplexed.

“没有,”我答道,感觉自己像个误入兄弟会派对的禁酒主义者。他一脸困惑。

Murphy asked how many audience members had prescribed peptides, and about half raised their hands. He reviewed some peptides that had been approved for specific indications—and thus could safely be prescribed to patients for other conditions—before turning his attention to gray-market peptides. Ipamorelin, for example, was “one of the cleanest” growth-hormone-releasing peptides. It could be given orally or—“illegally,” a slide read—as a subcutaneous injection. Murphy advised us to stick to off-label use of approved peptides, instead of prescribing their unapproved cousins. Otherwise, we might get a “nasty letter” from the F.D.A., or even lose our medical licenses.

墨菲问有多少听众曾开过肽类药物,约半数人举起了手。他先回顾了几种已获批用于特定适应症的肽类药物——这些药物因此可以安全地用于治疗其他病症——随后将注意力转向灰色市场的肽类产品。例如伊帕莫林(Ipamorelin)是“最纯净”的生长激素释放肽之一,既可口服,也可通过皮下注射使用——幻灯片上标注着“非法途径”。墨菲建议我们坚持使用已获批肽类药物的超适应症处方,而非开具其未获批的同类药物。否则,我们可能会收到美国食品药品监督管理局(F.D.A.)的“警告函”,甚至可能被吊销行医执照。

At the end of the talk, Lee stood to address the room. “We really need to save peptides!” he said. He exhorted the group to generate data on peptides, noting that he’d personally published three papers about BPC-157. “But I’m only one person,” he said. (Lee’s papers were not randomized and did not use control groups; the largest included sixteen patients and was published in a little-known journal.) On his way out, Lee handed me a copy of a book he’d written. Inside, he’d signed his name, along with a message: “Enjoy life with peptides.” ♦

演讲结束时,李(Lee)起身向全场致辞。“我们真的需要拯救肽!”他说。他敦促大家积极生成关于肽的数据,并提到自己已经发表了三篇关于BPC-157的论文。“但我只是一个人,”他说。(李的论文既非随机对照实验,也未设置对照组;其中规模最大的一项研究仅包含十六名患者,且发表在知名度较低的期刊上。)离场时,李递给我一本他写的书。扉页上有他的签名和一句赠言:“与肽共享人生之乐。” ♦

2 free previews left — register to get 30 translations a month